Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses by Pushparaj, P, Nicoletto, A, Castro Dopico, X, Sheward, DJ, Kim, S, Ekström, S, Murrell, B, Corcoran, M, Karlsson Hedestam, GB

Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies by Pushparaj, P, Nicoletto, A, Sheward, DJ, Das, H, Castro Dopico, X, Perez Vidakovics, L, Hanke, L, Chernyshev, M, Narang, S, Kim, S, Fischbach, J, Ekström, S, McInerney, G, Hällberg, BM, Murrell, B, Corcoran, M, Karlsson Hedestam, GB

Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies by Sheward, DJ, Pushparaj, P, Das, H, Greaney, AJ, Kim, C, Kim, S, Hanke, L, Hyllner, E, Dyrdak, R, Lee, J, Dopico, XC, Dosenovic, P, Peacock, TP, McInerney, GM, Albert, J, Corcoran, M, Bloom, JD, Murrell, B, Karlsson Hedestam, GB, Hällberg, BM

Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques by Mandolesi, M, Das, H, de Vries, L, Yang, Y, Kim, C, Dhinakaran, M, Castro Dopico, X, Fischbach, J, Kim, S, Guryleva, MV, Àdori, M, Chernyshev, M, Stålmarck, A, Hanke, L, McInerney, GM, Sheward, DJ, Corcoran, M, Hällberg, BM, Murrell, B, Karlsson Hedestam, GB